Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density
Other
OA: closed
CC0
⤵ 32 in-corpus citations
AI-generated summary
This study investigated the impact of extended postoperative dienogest treatment for endometriosis on bone mineral density in patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: This study was conducted to evaluate the effects of long-term postoperative dienogest (DNG) use for the treatment of endometriosis on bone mineral density (BMD).
STUDY DESIGN: Sixty reproductive-aged women who underwent conservative surgery for endometriomas and received postoperative DNG (2mg/day) for at least 12 months to prevent recurrence were analyzed. BMD was measured before and after DNG treatment by using dual energy X-ray absorptiometry, and changes in BMD were evaluated.
RESULTS: Mean patient age was 30.5 years, and mean duration of DNG treatment was 18.6 months. BMD at the lumbar spine significantly decreased after the first 6 months (-2.2%), and 1year (-2.7%) of DNG treatment, compared to baseline. The proportion of women who had significantly decreased BMD at the lumbar spine after 1year was 75% (45/60). In addition, BMD at the femur neck also decreased significantly after 1year (-2.8%). BMDs after 2 years were not different from those after 1year at both sites in 24 women who received DNG for ≥2years. In addition, there were no differences in baseline characteristics between women who had significantly reduced BMD at the lumbar spine after 1year (N=45) and women who did not (N=15).
CONCLUSION: This study suggests that long-term postoperative DNG treatment might have an adverse effect on BMD in reproductive-aged women. Bone loss mostly occurs during the first 6 months of treatment with DNG. A clinical trial is warranted to establish the effects of long-term DNG treatment on bone mass.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (21)
- ACOG Committee Opinion. Number 310, April 2005. Endometriosis in adolescents via openalex
- A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
- Current strategies for endometriosis management via openalex
- Dienogest: a review of its use in the treatment of endometriosis via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Endometriosis in adolescents via openalex
- Evaluation and treatment of endometriosis via openalex
- Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors via openalex
- Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis via openalex
- Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex
- Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women via openalex
- Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence via openalex
- Postoperative medical therapy after surgical treatment of endometriosis: from adjuvant therapy to tertiary prevention via openalex
- Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
- W6704180603 via openalex
- W1997810509 via openalex
- W2045458073 via openalex
- W2101417341 via openalex
- W18374401 via openalex
Cited by (36)
- Short-term safety of dienogest on bone mineral density in Iranian women with endometriosis: A cross-sectional study 2026
- Role of hormonal therapies in endometriosis: balancing efficacy and safety 2026
- Personalized endometriosis therapy: efficacy of surgical treatment and long-term medical control 2026
- Endometriosis-associated bone loss: re-evaluating the potential role of systemic inflammation and hypoestrogenic therapies 2026
- Maximising and Maintaining Fertility in Suspected or Confirmed Endometriosis: A Structured Narrative Review for Clinical Practice 2026
- Endometriosis and menopausal health: An EMAS clinical guide 2025
- Results of dienogest treatment and its discontinuation in patients with symptomatic adenomyosis: a prospective cohort study 2025
- Clinical Guidance Paper VVOG: Pharmacological treatment of endometriosis-related pain 2025
- A systematic review and Bayesian analysis of the adverse effects of dienogest 2024
- Schmerztherapie bei Patientinnen mit Endometriose 2024
- Schmerztherapie bei Patientinnen mit Endometriose 2023
- [Holistic treatment of endometriosis] 2023
- Modern approaches to the treatment of endometriosis (studing world and native recommendations) 2022
- Efficacy of Dienogest for Prevention of Endometriosis Recurrence: A Systematic Review and Meta-Analysis 2022
- Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study 2022
- Dysmenorrhea in Combination with Endometriosis in Adolescence and Early Reproductive Age 2022
- Endometriosis, an Ongoing Pain-Step-by-Step Treatment 2022
- Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study 2022
- Medical treatments of endometriosis: a review 2022
- Non-invasive diagnosis and non-surgical treatment of endometriosis: A review 2022
- Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest 2021
- Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study 2021
- [Management of endometriosis pain : Stage-based treatment strategies and clinical experience] 2021
- The Long-Term Effect of Dienogest on Bone Mineral Density After Surgical Treatment of Endometrioma 2021
- Relationship Between Bone Mineral Density and Ovarian Function in Perimenopausal Women With Endometriosis: A Prospective Study 2021
- Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis 2020
- Hormone therapy for patients with endometriosis: status update on the problem (literature review) 2020
- Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study 2020
- Use of dienogest in endometriosis: a narrative literature review and expert commentary 2020
- Bowel Endometriosis: Current Perspectives on Diagnosis and Treatment 2020
- Endometriosis: modern principles of diagnosis and treatment (literature review). Part 1. Therapy 2019
- Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery 2019
- Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain? 2018
- Effect of hormone modulation therapy on bone tissue in the treatment of endometriosis 2018
- Reviewing the role of progesterone therapy in endometriosis 2018
- Effect of alpha-lipoic acid on endometrial implants in an experimental rat model 2017
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:19:35.375178+00:00
- unpaywall
- last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0
· commercial use OK